Literature DB >> 1329341

Quantitative assessment of poxvirus promoters in fowlpox and vaccinia virus recombinants.

D B Boyle1.   

Abstract

A comparison was undertaken of poxvirus promoters in vaccinia and fowlpox virus (FPV) recombinants using the level of beta-galactosidase expressed from the LacZ gene as a measure of promoter function. In this study a comparison was made of the vaccinia virus promoters, P 7.5 and P L11, the major late promoter of cowpox virus, P CPX (expressing the abundant inclusion body protein), and the FPV promoters, P E/L and P L. In vaccinia virus recombinants the FPV P E/L promoter expressed one-third to one-half the level of beta-galactosidase expressed by the P L11 promoter. In comparison with the P 7.5 promoter, the FPV P E/L promoter expressed four to five times the level of beta-galactosidase. In FPV recombinants beta-galactosidase activity expressed was equal for the P E/L and P CPX promoters. Levels expressed by P L11 and P L were one-half and one-fifth that level, respectively. The temporal regulation of the promoters was maintained in both vaccinia virus and FPV recombinants. The P E/L promoter of FPV has the TAAATG sequence characteristic of late poxvirus promoters at the transcription initiation site. In an attempt to enhance the utility of this promoter for the expression of foreign genes in FPV and vaccinia virus recombinants, the effect upon promoter function of changing the G of the ATG to A, T, or C was determined using transient expression assays with vaccinia virus. Substitution of A, T, or C for the G abolished promoter function. Because of its early/late function, the level of expression and the presence of the oppositely oriented late P L promoter, the FPV P E/L promoter will be valuable for the expression of foreign genes in poxvirus recombinants.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1329341     DOI: 10.1007/bf01702566

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  28 in total

1.  A poxvirus bidirectional promoter element with early/late and late functions.

Authors:  S Kumar; D B Boyle
Journal:  Virology       Date:  1990-11       Impact factor: 3.616

2.  A poxvirus-derived vector that directs high levels of expression of cloned genes in mammalian cells.

Authors:  D D Patel; C A Ray; R P Drucker; D J Pickup
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

3.  Construction of recombinant fowlpox viruses as vectors for poultry vaccines.

Authors:  D B Boyle; B E Coupar
Journal:  Virus Res       Date:  1988-06       Impact factor: 3.303

4.  Comparative analysis of vaccinia virus promoter activity in fowlpox and vaccinia virus recombinants.

Authors:  C T Prideaux; S Kumar; D B Boyle
Journal:  Virus Res       Date:  1990-04       Impact factor: 3.303

5.  Activity of a fowlpox virus late gene promoter in vaccinia and fowlpox virus recombinants.

Authors:  S Kumar; D B Boyle
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

6.  Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus.

Authors:  P L Earl; A W Hügin; B Moss
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

7.  General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.

Authors:  M Mackett; G L Smith; B Moss
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

8.  Multiple-cloning-site plasmids for the rapid construction of recombinant poxviruses.

Authors:  D B Boyle; B E Coupar; G W Both
Journal:  Gene       Date:  1985       Impact factor: 3.688

9.  Messenger RNAs of a strongly-expressed late gene of cowpox virus contain 5'-terminal poly(A) sequences.

Authors:  D D Patel; D J Pickup
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

10.  Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen.

Authors:  A Townsend; J Bastin; K Gould; G Brownlee; M Andrew; B Coupar; D Boyle; S Chan; G Smith
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

View more
  5 in total

1.  The genome of fowlpox virus.

Authors:  C L Afonso; E R Tulman; Z Lu; L Zsak; G F Kutish; D L Rock
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 2.  Reflections on the early development of poxvirus vectors.

Authors:  Bernard Moss
Journal:  Vaccine       Date:  2013-04-10       Impact factor: 3.641

3.  Use of the Aerosol Rabbitpox Virus Model for Evaluation of Anti-Poxvirus Agents.

Authors:  Chad J Roy; Thomas G Voss
Journal:  Viruses       Date:  2010-09-27       Impact factor: 5.048

4.  RNA Polymerase Mutations Selected during Experimental Evolution Enhance Replication of a Hybrid Vaccinia Virus with an Intermediate Transcription Factor Subunit Replaced by the Myxoma Virus Ortholog.

Authors:  Carey A Stuart; Erik K Zhivkoplias; Tatiana G Senkevich; Linda S Wyatt; Bernard Moss
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

Review 5.  Recombinant fowlpox virus vaccines for poultry.

Authors:  D B Boyle; H G Heine
Journal:  Immunol Cell Biol       Date:  1993-10       Impact factor: 5.126

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.